A recent development in the UK’s National Health Service (NHS) has sparked concern among patient privacy advocates. Palantir, a data analytics company, is set to be granted access to NHS patient data. The scope of this access is still unclear, but it has been reported that the company will have ‘unlimited access’ to sensitive patient information.

This move has raised questions about data protection and the potential risks associated with sharing large amounts of personal data with a private company. The NHS has a long history of protecting patient confidentiality, and this decision may be seen as a departure from that principle.

As the situation unfolds, it remains to be seen how Palantir will use this data and what safeguards will be put in place to protect patient privacy. The UK government and the NHS will likely face scrutiny over this decision, and it is likely that further details will emerge in the coming days.

Photo by Adarsh Mp on Pexels
Photos provided by Pexels